Sam Brusco, Associate Editor03.23.22
Global contract manufacturer Lincotek acquired a majority stake in Italy-based Pegasus’ medical vision.
This grants the company access to Pegasus’ fully robotized forging line to manufacture forged implantable parts. These capabilities are supplemented with an AMS-2750-compliant heat treatment furnace; automated pickling line and liquid penetrant inspection unit; laboratory equipment; internal mold manufacturing; robotized deburring and polishing unit; and computerized dimensional control.
The 3,000 m2 forging facility opened in 2019 and was dedicated to orthopedic applications. It’s ISO 13485 and 17025 certified.
Winfried Schaller, CEO of Lincotek Group told the press: “With the acquisition of the majority stake in Pegasus medical division, Lincotek Medical is in a stronger position than ever before to support orthopedic OEMs. By combining this impressive forging service with our existing offering, we are able to help customers stay competitive and get to market even faster. It really is a new world of advanced automation and productivity.”
Speaking for Pegasus, Alberto Alaria, the company’s Managing Director, added: “Pegasus is proud to enter into partnership with Lincotek Group which represents a great opportunity to grow our presence in the forged medical implants market with the offering of high-quality products. The new synergies and product integration that will be generated moves us a step ahead and creates the possibility of further strengthening the cooperation with our valued customers.”
This grants the company access to Pegasus’ fully robotized forging line to manufacture forged implantable parts. These capabilities are supplemented with an AMS-2750-compliant heat treatment furnace; automated pickling line and liquid penetrant inspection unit; laboratory equipment; internal mold manufacturing; robotized deburring and polishing unit; and computerized dimensional control.
The 3,000 m2 forging facility opened in 2019 and was dedicated to orthopedic applications. It’s ISO 13485 and 17025 certified.
Winfried Schaller, CEO of Lincotek Group told the press: “With the acquisition of the majority stake in Pegasus medical division, Lincotek Medical is in a stronger position than ever before to support orthopedic OEMs. By combining this impressive forging service with our existing offering, we are able to help customers stay competitive and get to market even faster. It really is a new world of advanced automation and productivity.”
Speaking for Pegasus, Alberto Alaria, the company’s Managing Director, added: “Pegasus is proud to enter into partnership with Lincotek Group which represents a great opportunity to grow our presence in the forged medical implants market with the offering of high-quality products. The new synergies and product integration that will be generated moves us a step ahead and creates the possibility of further strengthening the cooperation with our valued customers.”